Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials

Scheen, AJ

Scheen, AJ (corresponding author), CHU Sart Tilman, B35, B-4000 Liege 1, Belgium.

DIABETES & METABOLISM, 2020; 46 (3): 186

Abstract

Aims. - This study compared the reduction of glycated haemoglobin (HbA1c) with sodium-glucose cotransporter type-2 inhibitors (SGLT2is) vs. dipeptidyl......

Full Text Link